Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Category Archives: Dawson James Conference

RXi Pharmaceuticals Corp. (RXII) Starts Presentation at Dawson James Conference

RXi Pharmaceuticals Corp. (NASDAQ: RXII) is a biotechnology company focused on discovering and developing innovative therapeutics that address high-unmet medical needs, primarily in the area of dermatology and ophthalmology. Its discovery and clinical development programs are based on siRNA technology … Continue reading

Posted in Dawson James Conference | Leave a comment

Nemus Bioscience, Inc. (NMUS) Starts Presentation at Dawson James Conference

Nemus Bioscience, Inc. (OTC: NMUS) is a biopharmaceutical company with a focus on the discovery, development and commercialization of therapeutics based on naturally-derived or synthetically manufactured cannabis compounds. The company develops therapeutic products to treat glaucoma and other optic nerve-related … Continue reading

Posted in Dawson James Conference | Leave a comment

Payment Data Systems, Inc. (PYDS) Starts Presentation at Dawson James Conference

Payment Data Systems, Inc. (NASDAQ: PYDS) is an integrated payment solutions provider to merchants and billers. The company provides an extensive set of products to deliver world-class payment acceptance. Payment Data has solutions for merchants, billers, banks, service bureaus and … Continue reading

Posted in Dawson James Conference | Leave a comment

Latitude 360, Inc. (LATX) Starts Presentation at Dawson James Conference

Latitude 360, Inc. (OTC: LATX) is an award-winning pioneer of combining premier upscale casual dining with state-of-the-art entertainment creating a “360 Experience” in its unique venues. The Company develops, constructs and operates cutting-edge Latitude 360 locations (from 50,000-70,000 sq. ft.) … Continue reading

Posted in Dawson James Conference | Leave a comment

BioLife Solutions, Inc. (BLFS) Starts Presentation at Dawson James Conference

BioLife Solutions, Inc. (NASDAQ: BLFS) is located in Bothell, Washington, on a high-tech campus that has roots as a dairy farm. The company manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues and organs. BioLife Solutions performs … Continue reading

Posted in Dawson James Conference | Leave a comment

Great Basin Scientific, Inc. (GBSN) Starts Presentation at Dawson James Conference

Founded in 2005, Great Basin Scientific, Inc. (NASDAQ: GBSN) is a molecular diagnostics company commercializing breakthrough technologies that improve ease-of-use and deliver better cost per result for sample-to-result molecular diagnostic testing. The company’s breakthrough molecular diagnostic system provides more diagnostics … Continue reading

Posted in Dawson James Conference | Leave a comment

VolitionRx Ltd. (VNRX) Starts Presentation at Dawson James Conference

Life sciences company VolitionRx (NYSE: VNRX) is developing diagnostic tests for cancer and other conditions. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid … Continue reading

Posted in Dawson James Conference | Leave a comment

Atossa Genetics, Inc. (ATOS) Starts Presentation at Dawson James Conference

Atossa Genetics Inc. (NASDAQ: ATOS) is focused on improving breast health through the development of innovative laboratory services, medical devices and therapeutics. The company’s laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. … Continue reading

Posted in Dawson James Conference | Leave a comment

Aeterna Zentaris, Inc. (AEZS) Starts Presentation at Dawson James Conference

Aeterna Zentaris, Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in the development and commercialization of novel treatments in the fields of oncology, endocrinology and women’s health. The company’s product pipeline includes Macrilen™, which is currently in phase III … Continue reading

Posted in Dawson James Conference | Leave a comment

Capnia, Inc. (CAPN) Starts Presentation at Dawson James Conference

Capnia, Inc. (NASDAQ: CAPN) develops diagnostic and therapeutic products based on its proprietary technology for the precision metering of gas flow. Operating primarily in the U.S., the company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition … Continue reading

Posted in Dawson James Conference | Leave a comment